首页 > 市场调查报告书 > 材料

包装/容器医药品包装

市场调查报告书

商品编码

1629917

全球永续药品包装市场 - 2024-2032

Global Sustainable Pharmaceutical Packaging Market - 2024-2032

出版日期: 2024年12月30日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024年，全球永续药品包装市场规模达919.4亿美元，预计2032年将达到2,729.8亿美元，2024-2032年预测期间复合年增长率为12.7%。

永续药品包装包括减少浪费、降低碳排放并促进回收或生物降解性的材料和设计。随着製药业面临来自消费者、监管机构和环境组织的压力，要求采取更永续的做法，这种方法变得越来越重要。永续包装不仅有助于减少产业对环境的影响，也符合全球永续发展目标。

市场动态：

驱动程式和限制

消费者对可回收和环保材料的偏好不断上升

消费者对可回收和环保材料的偏好日益影响永续药品包装市场。随着环境问题的日益严重，消费者越来越意识到包装废弃物对地球的有害影响。这种意识促使他们倡导製药公司采用永续实践，优先考虑由可回收、可生物降解或可再生资源製成的包装。因此，消费者行为的这种转变迫使製造商进行创新，并将环保材料融入其产品设计中，以符合具有环保意识的消费者的价值观。

製造商正在开发创新的可持续解决方案，以减少有害塑胶和其他材料对环境的影响。例如，2024年10月30日，拜耳在其知名品牌Aleve上推出了医疗保健产业首创的聚对苯二甲酸乙二醇酯（PET）吸塑包装。

对环保包装不断增长的需求正在推动製药业对研发的大量投资。公司正在探索传统塑胶的替代品，选择玻璃、纸张和可生物降解聚合物等材料。例如，2023 年 11 月 7 日，ACG 推出了新的永续包装技术。这些创新旨在增强製药业的环境责任和营运效率。这些环保包装解决方案的推出标誌着 ACG 在永续发展和创新承诺方面向前迈出了重要一步。

与环保材料相关的高成本

永续包装解决方案通常需要先进的技术、专用材料和独特的生产工艺，这可能导致製造成本显着增加。对于利润率较低的製药公司来说，这些额外费用可能会带来相当大的挑战。此外，与某些环保材料（例如可生物降解塑胶和再生资源）相关的价格波动会导致金融不稳定，从而阻碍其在市场上更广泛的采用。

Sustainable pharmaceutical packaging encompasses materials and designs that reduce waste, lower carbon emissions, and promote recycling or biodegradability. This approach is increasingly important as the pharmaceutical industry faces pressure from consumers, regulators, and environmental organizations to adopt more sustainable practices. Sustainable packaging not only helps in reducing the industry's environmental impact but also aligns with global sustainability goals.

Market Dynamics: Drivers & Restraints

Rising consumer preference for recyclable and eco-friendly materials

Consumer preference for recyclable and eco-friendly materials is increasingly influencing the sustainable pharmaceutical packaging market. As environmental concerns rise, consumers are becoming more aware of the detrimental effects of packaging waste on the planet. This awareness is prompting them to advocate for pharmaceutical companies to adopt sustainable practices, prioritizing packaging made from recyclable, biodegradable, or renewable resources. Consequently, this shift in consumer behavior is compelling manufacturers to innovate and integrate eco-friendly materials into their product designs, aligning with the values of environmentally conscious consumers.

Manufacturers are developing innovative sustainable solutions to reduce the impact of harmful plastic and other materials on the environment. For instance, on October 30, 2024, Bayer launched a first-of-its-kind in the healthcare industry, polyethylene terephthalate (PET) blister packaging on its renowned brand, Aleve.

The growing demand for eco-friendly packaging is driving significant investments in research and development within the pharmaceutical industry. Companies are exploring alternatives to traditional plastics, opting for materials such as glass, paper, and biodegradable polymers. For instance, on November 07, 2023, ACG launched its new sustainable packaging technologies. These innovations are designed to enhance environmental responsibility and operational efficiency within the pharmaceutical sector. The introduction of these eco-friendly packaging solutions marks a significant step forward in ACG's commitment to sustainability and innovation.

High costs associated with eco-friendly materials

Sustainable packaging solutions often require advanced technologies, specialized materials, and unique production processes, which can lead to significantly higher manufacturing costs. For pharmaceutical companies that operate on tight profit margins, these additional expenses can present a considerable challenge. Furthermore, the price fluctuations associated with certain eco-friendly materials, such as biodegradable plastics and renewable resources cause financial instability that could hinder their broader adoption in the market.

Segment Analysis

The global sustainable pharmaceutical packaging market is segmented based on packaging type, process, raw material, product type, end-user, and region.

Type:

Recyclable segment is expected to dominate the global sustainable pharmaceutical packaging market share

Recyclable sustainable pharmaceutical packaging is anticipated to dominate the market due to its increasing popularity among consumers, regulatory pressures, and cost-effectiveness. As awareness of environmental concerns continues to grow globally, consumers are seeking packaging solutions that minimize waste and support sustainability.

Recyclable packaging offers a practical, eco-friendly option, allowing pharmaceutical companies to meet consumer demands while reducing their environmental impact. The ability to recycle materials not only helps reduce waste sent to landfills but also supports the circular economy, where resources are reused, making recyclable packaging a preferred solution.

Additionally, the rising initiatives to recycle pharmaceutical wastes and packaging solutions are encouraging the adoption of recyclable packaging solutions in the pharmaceutical industries. For instance, on April 29, 2024, the United Kingdom launched The Circularity in Primary Pharmaceutical Packaging Accelerator (CiPPPA) initiative to develop and implement strategies for the end-of-use recycling of medicinal devices and pharmaceutical packaging.

Moreover, governments worldwide are implementing stricter packaging waste regulations, encouraging companies to shift towards recyclable materials. In response, pharmaceutical manufacturers are adopting recyclable packaging to comply with these policies and avoid potential penalties. Advancements in recycling technology are also enhancing the efficiency and practicality of recycling processes, making recyclable packaging more affordable and viable. This combination of consumer demand, regulatory incentives, and technological improvements is driving recyclable packaging to become a dominant force in the sustainable pharmaceutical packaging market.

Geographical Analysis

North America is expected to hold a significant position in the global sustainable pharmaceutical packaging market share

North America is expected to lead the sustainable pharmaceutical packaging market due to a variety of factors, such as growing consumer demand for eco-friendly products, stricter government regulations, and the presence of major industry players. Consumers in the region are increasingly concerned about environmental issues like climate change and plastic pollution, which has led to a rising demand for more sustainable packaging options.

In response, pharmaceutical companies in North America are focusing on adopting eco-friendly packaging solutions to meet these consumer expectations. This shift is further supported by a collective effort from both consumers and businesses to reduce waste and lessen their environmental impact, making North America a leader in sustainable packaging adoption.

In addition, government policies in North America are playing a significant role in driving the growth of sustainable pharmaceutical packaging. Both the U.S. and Canadian governments have introduced more stringent regulations on environmental practices and packaging waste management, motivating pharmaceutical companies to explore greener alternatives.

North America has several pharmaceutical manufacturers and packaging providers who are investing in new technologies and research to create innovative, sustainable packaging materials. For instance, in October 2024, Berry Global launched a range of clarified polypropylene (PP) bottles for healthcare applications, which offer sustainability and enhanced product protection compared to traditional colored PET pill bottles. ClariPPil bottles are ideal for a wide variety of products including vitamins, nutraceuticals, dietary supplements, beauty supplements, and OTC treatments.

This combination of industry collaboration, favorable economic conditions, and access to advanced technologies positions North America as a key driver in the global market for sustainable pharmaceutical packaging.

Asia Pacific is growing at the fastest pace in the global Sustainable Pharmaceutical Packaging market

The Asia Pacific region is experiencing the fastest growth in the global sustainable pharmaceutical packaging market due to several factors, including rapid industrial development, increasing consumer awareness, and evolving government regulations. As pharmaceutical industries in countries like China and India continue to expand, there is an increasing demand for packaging solutions that meet sustainability objectives. This shift is largely driven by a growing, environmentally conscious middle class, which is encouraging companies to embrace eco-friendly packaging alternatives.

The rising concerns about plastic waste and environmental impact in the region are prompting both consumers and businesses to prioritize sustainable packaging options, fueling the growth of the sustainable pharmaceutical packaging sector. The market players in the region are expanding their production of sustainable pharmaceutical packaging solutions which is also contributing to the region's market growth. For instance, on 6 November 2023, Amcor launched the next generation of its Medical Laminates solutions. Amcor's latest innovation enables the development of all-film packaging that is recyclable in the polyethylene stream. The new solution reduces the carbon footprint of the final package while maintaining the performance requirements of device applications, helping medical companies to progress their sustainability goals without compromising patient safety.

Competitive Landscape

The major global players in the sustainable pharmaceutical packaging market include Amcor plc, Berry Global Inc., Gerresheimer AG, WestRock Company, Drug Plastics & Glass Co., Inc., CCL Healthcare, Comar, Bormioli Pharma S.p.A., Origin Pharma Packaging and Ascend Packaging Systems LLC. among others.

Key Developments

In July 2024, Aluflexpack announced the development of a new product: the 4-Infinity Form. This blister pack, designed specifically for the pharmaceutical industry, is constructed entirely of lacquered aluminum, offering a sustainable and recyclable alternative to traditional multi-material packaging.
April 2022, Amcor announced the addition of new, more sustainable High Shield laminates to its pharmaceutical packaging portfolio. The new low-carbon, recycle-ready packaging options deliver on two fronts, providing the high barrier and performance requirements needed for the industry while supporting pharmaceutical companies' recyclability agendas.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Global sustainable pharmaceutical packaging market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Packaging Type
3.2. Snippet by Process
3.3. Snippet by Raw Material
3.4. Snippet by Product Type
3.5. Snippet by End-User
3.6. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rising consumer preference for recyclable and eco-friendly materials
- 4.1.2. Restraints
  - 4.1.2.1. High costs associated with eco-friendly materials
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Patent Analysis
5.5. Regulatory Analysis
5.6. SWOT Analysis
5.7. Unmet Needs

6. By Packaging Type

6.1. Introduction
- 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
- 6.1.2. Market Attractiveness Index, By Packaging Type
6.2. Primary Packaging*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Secondary Packaging

7. By Process

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process
- 7.1.2. Market Attractiveness Index, By Process
7.2. Recyclable*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Reusable
7.4. Biodegradable

8. By Raw Material

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
- 8.1.2. Market Attractiveness Index, By Raw Material
8.2. Paper & Paperboard*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Glass
8.4. Bioplastics
8.5. Metal
8.6. Others

9. By Product Type

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.1.2. Market Attractiveness Index, By Product Type
9.2. Blisters*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Labels & Accessories
9.4. Caps & Closures
9.5. Pre-filled Inhalers
9.6. Vials
9.7. Pre-filled Syringes
9.8. Ampoules
9.9. Cartridges
9.10. Others

10. By Raw Material

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
- 10.1.2. Market Attractiveness Index, By Raw Material
10.2. Paper & Paperboard*
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Glass
10.4. Bioplastics
10.5. Metal
10.6. Others

11. By Region

11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 11.1.2. Market Attractiveness Index, By Region
11.2. North America
- 11.2.1. Introduction
- 11.2.2. Key Region-Specific Dynamics
- 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
- 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process
- 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
- 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.2.8.1. U.S.
  - 11.2.8.2. Canada
  - 11.2.8.3. Mexico
11.3. Europe
- 11.3.1. Introduction
- 11.3.2. Key Region-Specific Dynamics
- 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
- 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process
- 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
- 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.3.8.1. Germany
  - 11.3.8.2. U.K.
  - 11.3.8.3. France
  - 11.3.8.4. Spain
  - 11.3.8.5. Italy
  - 11.3.8.6. Rest of Europe
11.4. South America
- 11.4.1. Introduction
- 11.4.2. Key Region-Specific Dynamics
- 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
- 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process
- 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
- 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.4.8.1. Brazil
  - 11.4.8.2. Argentina
  - 11.4.8.3. Rest of South America
11.5. Asia-Pacific
- 11.5.1. Introduction
- 11.5.2. Key Region-Specific Dynamics
- 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
- 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process
- 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
- 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.5.8.1. China
  - 11.5.8.2. India
  - 11.5.8.3. Japan
  - 11.5.8.4. South Korea
  - 11.5.8.5. Rest of Asia-Pacific
11.6. Middle East and Africa
- 11.6.1. Introduction
- 11.6.2. Key Region-Specific Dynamics
- 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
- 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process
- 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
- 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape

12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis

13. Company Profiles

13.1. Amcor plc*
- 13.1.1. Company Overview
- 13.1.2. Product Portfolio and Description
- 13.1.3. Financial Overview
- 13.1.4. Key Developments
13.2. Berry Global Inc.
13.3. Gerresheimer AG
13.4. WestRock Company
13.5. Drug Plastics & Glass Co., Inc.
13.6. CCL Healthcare
13.7. Comar
13.8. Bormioli Pharma S.p.A.
13.9. Origin Pharma Packaging
13.10. Ascend Packaging Systems LLC.

LIST NOT EXHAUSTIVE